STOCK MARKET BSE NSE

Neither a rich man’s disease nor a poor man’s

Six-year-old Vineeth Dev is busy watching cartoons on his father’s laptop at Indira Gandhi Institute of Child Health’s Centre of Excellence for Rare Diseases.

Published: 04th September 2017 01:51 AM  |   Last Updated: 04th September 2017 07:48 AM   |  A+A-

Eleven-year-old Prajwal suffers from Gaucher disease | vinod kumar T

Express News Service

BENGALURU: Six-year-old Vineeth Dev is busy watching cartoons on his father’s laptop at Indira Gandhi Institute of Child Health’s Centre of Excellence for Rare Diseases. His enzyme replacement therapy is under way and will take a lot of time. He suffers from Hunter’s Syndrome. The enzyme that Vineeth needs is  manufactured by only one other company, Shire, not registered in India, making its procurement difficult.

Teenager Nidhi Shirol suffers from
Pompe disease and has to undergo
zyme transfusion every 15 days

Luckily, his  father’s software firm crowdsourced `62 lakh by collecting `500 each from every employee towards Vineeth’s treatment. Vamsi Krishna, the father, doesn’t know what to do once they run out of the drugs. “My son’s therapy started two months  ago. After six months, I don’t know what to do,” he said. His wife Vidya says, “There are a couple of children who are getting treatment free of cost under Shire’s charitable access programme. But Vineeth is not covered because they sponsor limited number of patients only.”

Dr  Sanjeeva G N, the paediatrician who runs the Centre, says if there is a policy on rare disease in place, which acknowledges that each rare disease is different and the treatment cost keeps increasing exponentially with every kilogram the child puts on, the funding  process will become institutionalised and there will be a corpus to  turn to.

Eleven-year-old Prajwal H chats up with his  mother Vanitha J as his infusion is under way, saline dripping down his  arm. His father works as a salesman in a clothing showroom. “His father earns `20,000 per month. How can we afford `5 lakh worth of drugs  per month? He suffers from Gaucher. People say he looks normal and question why he should get an exemption in anything,” Vanitha says.
Gaucher is characterised by bruising, fatigue, anaemia, low blood platelet count and enlargement of the liver and spleen, and is  caused by a hereditary deficiency of a particular enzyme. Prajwal attends cricket coaching at a local academy and has also played in zonal level matches. Continuous treatment enabled him to do that, his mother says.

Nidhi Shirol (19) sits patiently on a reclining sofa while she undergoes enzyme transfusion. It takes around 12 hours for the transfusion to be completed and she has to undergo this every 15 days. She suffers from Pompe disease that doesn’t allow her muscles to function normally.
The Centre was set up in public-private partnership with Organisation for Rare Diseases, a national-level parents’ support group for children suffering from ultra rare diseases in India, co-founded by Nidhi’s father Prasanna Shirol.

Nidhi is a BCom student and until recently, her mother Sharada Shirol would accompany her to class. Sharada recalls her struggle, “I remember when we went to private hospitals, they would ask us to come at a time convenient to them. Here, we are so well received.”

Stay up to date on all the latest Bengaluru news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp